“I think you have to kill the disease of inflation,” Icahn told the Financial Times ahead of the Fed’s rate-setting meeting next week It is expected to increase its benchmark basis point.
The activist investor also warned that pressures outside the financial sector are also high, with many companies wasting dollars on flawed acquisitions. billion, and racked up debt in the process, the report said.
he told the FT that this would cause “significant problems” for the wider economy.
Icahn has been urging Illumina (NASDAQ) to Code: 1000ILMN) spins off cancer test developer Grail Inc, which said it would divest if its appeal to the European Commission fails, regulators said last year they intended to require the A life sciences company canceled a $7.1 billion acquisition.
report, Icahn added that the fight with the EU could take many years and that the only way out would be for Illumina to divest assets. 100